Hikal Limited

NSE HIKAL.NS

Hikal Limited EPS (Diluted) for the year ending March 31, 2024: USD 0.07

Hikal Limited EPS (Diluted) is USD 0.07 for the year ending March 31, 2024, a -12.62% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Hikal Limited EPS (Diluted) for the year ending March 31, 2023 was USD 0.08, a -54.87% change year over year.
  • Hikal Limited EPS (Diluted) for the year ending March 31, 2022 was USD 0.17, a 16.26% change year over year.
  • Hikal Limited EPS (Diluted) for the year ending March 31, 2021 was USD 0.15, a 62.26% change year over year.
  • Hikal Limited EPS (Diluted) for the year ending March 31, 2020 was USD 0.09, a -24.44% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
NSE: HIKAL.NS

Hikal Limited

CEO Mr. Jai Vishwanath Hiremath
IPO Date July 1, 2002
Location India
Headquarters Great Eastern Chambers
Employees 2,061
Sector Health Care
Industries
Description

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Similar companies

AARTIDRUGS.NS

Aarti Drugs Limited

USD 4.85

-0.49%

INDOCO.NS

Indoco Remedies Limited

USD 3.76

0.04%

GRANULES.NS

Granules India Limited

USD 6.74

2.92%

FDC.NS

FDC Limited

USD 5.56

1.72%

SEQUENT.NS

Sequent Scientific Limited

USD 2.07

5.03%

StockViz Staff

January 15, 2025

Any question? Send us an email